Skerryvore focuses on delivering investors absolute returns via an active index unaware strategy. It invests in companies with sustainable and resilient business practices that are aligned with its investors’ interests, have robust balance sheets and strong pricing power.
Jonas Daly, Chief of Distribution and Marketing at Bennelong Funds Management, said that Skerryvore was pleased to establish the mandate with the CFS FirstChoice team, now offering Australian advisers and investors access to the global award-winning Fund through the platform.
“The Skerryvore team has a strong long-term track record in emerging markets, and the focus on resilient franchises, governance and political risk has always been a key part of their investment philosophy and process. Having the Fund added to the platform and accessible to our First Choice clients is a great win for us all.”
The Fund was awarded the 2023 Morningstar Australia Fund Manager of the Year ‘Undiscovered Manager’. It is rated Gold by Morningstar, Recommended by Lonsec, Recommended by Zenith and Superior by SQM*.
The content contained in this article represents the opinions of the authors. The authors may hold either long or short positions in securities of various companies discussed in the article. The commentary in this article in no way constitutes a solicitation of business or investment advice. It is intended solely as an avenue for the authors to express their personal views on investing and for the entertainment of the reader.
*Source: Morningstar Global Fund Report published on 9 March 2023 for Skerryvore Global Emerging Markets All-Cap Equity strategy. Source: 2023 Morningstar Awards - Australia Winners - News Release. The Morningstar Analyst Rating™ for Skerryvore Global Emerging Markets All-Cap Equity Fund is ‘Gold’ as of 06/02/2023. Morningstar Awards 2023 (c). Morningstar, Inc. All Rights Reserved. Awarded to Skerryvore Global Emerging Markets All Cap Equities Fund Manager of the Year - Undiscovered Manager category, Australia. © 2023 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This report or data has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or New Zealand wholesale clients of Morningstar Research Ltd, subsidiaries of Morningstar, Inc. Any general advice has been provided without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide at www.morningstar.com.au/s/fsg.pdf. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Morningstar’s publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782.
The Lonsec rating issued - 04/2023, Skerryvore Global Emerging Markets All-Cap Equity Fund is published by Lonsec Research Pty Ltd ABN 11 151 658 561 AFSL 421 445 (Lonsec). Ratings are general advice only, and have been prepared without taking account of your objectives, financial situation or needs. Consider your personal circumstances, read the product disclosure statement and seek independent financial advice before investing. The rating is not a recommendation to purchase, sell or hold any product. Past performance information is not indicative of future performance. Ratings are subject to change without notice and Lonsec assumes no obligation to update. Lonsec uses objective criteria and receives a fee from the Fund Manager. Visit lonsec.com.au for ratings information and to access the full report. © 2023 Lonsec. All rights reserved.
The Zenith Investment Partners (ABN 27 103 132 672, AFS Licence 226872) (“Zenith”) rating (assigned 06/2022, Skerryvore Global Emerging Markets All-Cap Equity Fund) referred to in this piece is limited to “General Advice” (s766B Corporations Act 2001) for Wholesale clients only. This advice has been prepared without taking into account the objectives, financial situation or needs of any individual, including target markets of financial products, where applicable, and is subject to change at any time without prior notice. It is not a specific recommendation to purchase, sell or hold the relevant product(s). Investors should seek independent financial advice before making an investment decision and should consider the appropriateness of this advice in light of their own objectives, financial situation and needs. Investors should obtain a copy of, and consider the PDS or offer document before making any decision and refer to the full Zenith Product Assessment available on the Zenith website. Past performance is not an indication of future performance. Zenith usually charges the product issuer, fund manager or related party to conduct Product Assessments. Full details regarding Zenith’s methodology, ratings definitions and regulatory compliance are available on our Product Assessments and at Fund Research Regulatory Guidelines.
The SQM ratings contained in this document are issued by SQM Research Pty Ltd ABN 93 122 592 036. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.
